LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

Home・Akcijų sąrašas・Axsome Therapeutics Inc

Axsome Therapeutics Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

147.59 -0.76

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

146.93

Max

150.62

Pagrindiniai rodikliai
By Trading Economics
Pajamos	744K -47M
Pardavimai	21M 171M
Pelnas, tenkantis vienai akcijai	-0.94
Pelno marža	-27.621
Darbuotojai	816
EBITDA	-7.7M -44M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+17.44% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	792M 7.5B
Ankstesnė atidarymo kaina	148.35
Ankstesnė uždarymo kaina	147.59

Naujienos nuotaikos

By Acuity

12%

88%

6 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bearish Evidence

107.24 / 112.29 Palaikymas ir pasipriešinimas

Axsome Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-08 23:48; UTC

Pagrindinės rinkos jėgos

Shares of Sezzle and Vital Farms Rise on S&P SmallCap 600 Inclusion

2025-12-08 23:44; UTC

Rinkos pokalbiai

Perky Australian Dollar Looks to Extend Gains -- Market Talk

2025-12-08 23:42; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Uncertainty Over Econ, Earnings -- Market Talk

2025-12-08 23:13; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-08 23:13; UTC

Rinkos pokalbiai

Australian Inflation Expectations Highest Since Late 2023 -- Market Talk

2025-12-08 23:09; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Made a Hostile Bid for Warner After Netflix Deal. What Happens Next? -- WSJ

2025-12-08 22:46; UTC

Rinkos pokalbiai

Rio Tinto Building Low-Cost Lithium Business in Difficult Market -- Market Talk

2025-12-08 22:01; UTC

Rinkos pokalbiai

Miners Poised to Do Well in 2026 -- Market Talk

2025-12-08 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Noble: Agreement With Borr Includes Sale of Noble Tom Prosser, Noble Mick O'Brien, Noble Regina Allen, Noble Resilient, Noble Resolute, Closing Expected in Early 2026 >NE

2025-12-08 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Noble: Agreement With Borr Comprises $210M in Cash and $150M in Seller Notes >NE

2025-12-08 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Noble: Agreement With Ocean Oilfield Drilling Anticipates the Sale of the Noble Resolve, Closing Is Expected in 2Q 2026, Upon Conclusion of Noble Resolve's Current Contract >NE

2025-12-08 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Noble: To Sell Five Rigs to Borr Drilling Limited for $360M and One Rig to Ocean Oilfield Drilling for $64M in Cash >NE

2025-12-08 21:51; UTC

Rinkos pokalbiai

US-Canada Rate Spreads Narrow Sharply After Record Gap -- Market Talk

2025-12-08 21:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2025-12-08 21:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-12-08 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-08 21:38; UTC

Įsigijimai, susijungimai, perėmimai

Boeing Buys Company Responsible for Door Blowout. The Stock Rises. -- Barrons.com

2025-12-08 21:38; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Makes $77.9 Billion Hostile Bid for Warner After Netflix Struck Deal -- 7th Update

2025-12-08 21:36; UTC

Rinkos pokalbiai

Oil Oversupply to Show Up As Waterborne Stocks Land -- Market Talk

2025-12-08 21:20; UTC

Įsigijimai, susijungimai, perėmimai

Will the Netflix-Warner Bros. Merger Go Through? It Depends on How You Define Market Share. -- Barrons.com

2025-12-08 21:12; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Moved the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

2025-12-08 21:08; UTC

Rinkos pokalbiai

Rosenberg Turns 'Outright Bullish' on Canada Dollar -- Market Talk

2025-12-08 20:38; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Netflix Co-CEOs Confident About Regulatory Approval for WBD Deal -- Market Talk

2025-12-08 20:26; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

2025-12-08 20:18; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Netflix Isn't Looking to Make Cuts at Warner Bros. Discovery -- Market Talk

2025-12-08 20:07; UTC

Rinkos pokalbiai

Oil Futures Snap Three-Session Winning Streak -- Market Talk

2025-12-08 20:06; UTC

Rinkos pokalbiai

U.S. Natural Gas Pulls Back From Weather-Driven Highs -- Market Talk

2025-12-08 20:05; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-12-08 20:05; UTC

Rinkos pokalbiai

Deere Offers Sales Growth Forecast Through 2030 -- Market Talk

2025-12-08 20:01; UTC

Rinkos pokalbiai

Precious Metals Slip Ahead of Fed Decision -- Market Talk

Akcijų palyginimas

Kainos pokytis

Axsome Therapeutics Inc Prognozė

Kainos tikslas

By TipRanks

17.44% į viršų

12 mėnesių prognozė

Vidutinis 175.25 USD 17.44%

Aukščiausias 202 USD

Žemiausias 148 USD

Remiantis 15 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Axsome Therapeutics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

15 ratings

Pirkti

Laikyti

Parduoti

Remiantis 15 analitikų, pateikusių Axsome Therapeutics Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

107.24 / 112.29Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

All events are bullish.

Rinkos nuotaikos

By Acuity

6 / 374 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Axsome Therapeutics Inc

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial for treating attention-deficit/hyperactivity disorder, and is in phase 2 major depressive, binge eating, and shift work disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.